Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 232-240

  Kurokohchi, Kazutaka ^a   Akatsuka, Toshitaka ^b   Pendleton, C David ^a   Takamizawa, Akihisa ^c   Nishioka, Mikio ^d   Battegay, Manuel ^b   Feinstone, Stephen M ^b   Berzofsky, Jay A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Center for Biologics Evaluation/Res   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; HLA ANTIBODY; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OKT 4; OKT 8; PROTEINASE; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; PEPTIDE MAPPING; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BINDING SITES; CHRONIC DISEASE; EPITOPE MAPPING; EPITOPES; HEPACIVIRUS; HEPATITIS C; HLA-A2 ANTIGEN; HUMAN; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC; TRYPSIN; TUMOR CELLS, CULTURED; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0029655564     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.232-240.1996     Document Type: Article

References (78)

1. Achour, A., O. Picard, J.-P. Mbika, A. Willer, R. Snart, B. Blzzini, C. Carelli, A. Burny, and D. Zagury. 1993 Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope. Vaccine 11:699-701.
2. Alter, H. J., R. H. Purcell, J. W. Shih, J. C. Melpolder, M. Hnughton, Q.-L. Choo, and G. Kuo. 1989. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N. Engl J Med. 321:1494-1500.
3. Battegay, M., J. Fikes, A. M. Di Bisceglie, P. A. Wentworth, A. Sette, E. Celis, W.-M. Ching, A. Grakoui, C. M. Rice, K. Kurokohchi, J. A. Berzofsky, J. H. Hoofnagle, S. M. Feinstone, and T. Akatsuka. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2 1 molecules. J Virol 69:2462-2470.
4. Bradley, D. W., K. A. McCaustland, E. H. Cook, C. A. Schable, J. W. Ebert, and J. E. Maynard. 1985. Posrtransfusion non-A, non-B hepatitis in chimpanzees: physicochemical evidence that the tubule-forming agent is a small, enveloped virus. Gastroenterology 88:773-779.
5. Byrne, J. A., and M. B. A. Oldstone. 1984 Biology of cloned cytotoxic T lymphocytes specific for lymphocylic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:682-686.
6. Carbone, F. R., M. W. Moore, J. M. Sheil, and M. J. Bevan. 1988. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. J. Exp. Med. 167:1767-1779.
7. Cease, K. B., and J. A. Berzofsky. 1994 Towards a vaccine for AIDS: the emergence of immunobiology-based vaccine development. Annu. Rev. Im-munol. 12:925-989.
8. Cerny, A., C. Ferrari, and F. V. Chisari. 1994 The class 1-restricted cytotoxic T lymphocyte response to predetermined epitopes in the hepatitis B and C viruses Curr. Top. Microbiol Immunol. 189:169-186
9. Choo, Q.-L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
10. Choc, Q.-L., K. H. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, A. Medina-Selby, P. J. Barr, A. J. Weiner, D. W. Bradley, G. Kuo, and M. Houghton. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:2451-2455.
11. Collett, M. S., D. Anderson, and E. Retzel. 1988. Comparisons of the pestivirus bovine viral diarrhoea virus with members of the flaviviridae. J. Gen Virol 69:2637-2643.
12. Cristiano, K., A. M. Di Bisceglie, J. II. Hoofnagle, and S. M. Feinstone. 1991. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology 14:51-55.
13. Di Bisceglie, A. M., and J. H. Hoofnagle. 1991. Therapy of chronic hepatitis C with α-interferon: the answer? or more questions? Hepatology 13:601-603.
14. Dick, L. R., C. Aldrich, S. C. Jameson, C. R. Moomaw, B. C. Pramanik, C. K. Doyle, G. N. DcMartino, M. J. Bevan, J. M. Forman, and C. A. Slaughter. 1994. Proteolytic processing of ovalbumin and β-galactosidase by the proteasome to yield antigenic peptides. J. Immunol. 152:3884-3894.
15. Earl, P. L., B. Moss, R. P. Morrison, K. Wehrly, J. Nishio, and B. Chesebro. 1986. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Science 234:728.
16. Erickson, A. L., M. Houghton, Q.-L. Choo, A. J. Weiner, R. Ralston, E. Muchmore, and C. M. Walker. 1993. Hepatitis C virus-specific responses in the liver of chimpanzees with acute and chronic hepatitis C. J. Immunol. 151:4189-4199.
17. Esteban, J. I., R. Esteban, L. Viladomiu, J. C. López-Talavera, A. González, J. M. Hernández, M. Roget, V. Vargas, J. Genescà, M. Buti, J. Guardia, M. Houghton, Q.-L. Choo, and G. Kuo. 1989. Hepatitis C virus antibodies among risk groups in Spain. Lancet ii:294-296.
18. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (London) 351:290-296.
19. Feinstone, S. M., H. J. Alter, H. P. Dienes, Y. Shimizu, H. Popper, D. Blackmore, D. Sly, W. T. London, and R. H. Purcell. 1981 Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect. Dis. 144:588-598.
20. Fields, G. B., and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxcarbonyl amino acids Int. J. Peptide Protein Res. 35:161-214.
21. Gavin, M. A., M. J. Gilbert, S. R. Riddell, P. D. Greenberg, and M. J. Bevan. 1993. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J. Immunol. 151:3971-3980.
22. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403-450.
23. Goodman, J. W., and E. E. Sercarz. 1983. The complexity of structures involved in T-cell activation. Annu. Rev. Immunol. 1:465-498.
24. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993 A second hepatitis C virus-encoded proteinase. Proc. Natl. Acad. Sci. USA 90:10583-10587.
25. Grakoui, A., D. W. McConrt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993. Characterization of the hepatitis C virus-encoded serine proteinase. determination of proteinase-dependent polyprotein cleavage sites J Virol. 67:2832-2843.
26. Grakoui, A., C. Wychowski, C. Lin, S. M. Feinstone, and C. M. Rice. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1385-1395.
27. He, L.-F., D. Alling, T. Popkin, M. Shapiro, H. J. Alter, and R. H. Purcell. 1987. Determining the size of non-A, non-B hepatitis virus by nitration. J. Infect. Dis. 156:636-640.
28. Heath, W. R., K. P. Kane, M. F. Mescher, and L. A. Sherman. 1991. Allo-reactive T cells discriminate among a diverse set of endogenous peptides. Proc. Natl. Acad. Sci USA 88:5101-5105.
29. Henderson, R. A., H. Michel, K. Sakaguchi, J. Shabanowitz, E. Appella, D. F. Hunt, and V. H. Engelhard. 1992 HLA-A2 1-associated peptides from a mutant cell line: a second pathway of antigen presentation Science 255:1264-1266.
30. Hijikata, M., H. Mizushima, T. Akagi, S. Mori, N. Kakiuehi, N. Kato, T. Tanaka, K. Kimura, and K. Shimotohno. 1993. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J. Virol 67:4665-4675.
31. Hijikata, M., H. Mizushima, Y. Tanji, Y. Komoda, Y. Hirowatari, T. Akagi, N. Kato, K. Kimura, and K. Shimotohno. 1993 Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus Proc. Natl. Acad Sci USA 90:10773-10777
32. + T cells. J. Immunol. 149:1319-1325
33. Houghton, M., A. Weiner, J. Han, G. Kuo, and Q.-L. Choo. 1991. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and Lontrol of viral disease Hepatology 14:381-388.
34. Houmard, J., and G. R. Drapeau. 1972. Staphylococcal protease: proteolytic enzyme specific for glutamoyl bonds. Proc. Natl. Acad. Sci. USA 69:3506-3509.
35. Hunt, D. F., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E. Appella, and V. H. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261-1263.
36. Imawari, M., M. Nomura, T. Kaieda, T. Moriyama, K. Oshimi, I. Nakamura, T. Gunji, S. Ohnishi, T. Ishikawa, H. Nakagama, and F. Takaku. 1989. Establishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus. Proc. Natl. Acad. Sci. USA 86:2883-2587.
37. Inchauspe, G., S. Zebedee, D.-H. Lee, M. Sugitani, M. Nasoff, and A. M. Prince. 1991. Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc. Natl. Acad. Sci. USA 88:10292-10296.
38. Kast, W. M., R. M. P. Brandt, J. W. Drijfhout, and C. J. M. Melief. 1993. Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2 J. Immunother. 14:115-120.
39. Kast, W. M., R. M. P. Brandt, J. Sidney, J.-W. Drijfhout, R. T. Kubo, H. M. Grey, C. J. M. Melief, and A. Sette. 1994. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152:3904-3912
40. Kast, W. M., R. Offringa, P. J. Peters, A. C. Voordouw, R. H. Meloen, A. J. van der Eb, and C. J. M. Melief. 1989 Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 59:603-614.
41. Kita, H., T. Moriyama, T. Kaneko, I. Harase, M. Nomura, H. Miura, I. Nakamura, Y. Yazaki, and M. Imawari. 1993. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039-1044.
42. Kiyosawa, K., T. Sodeyama, E. Tanaka, Y. Gibo, K. Yoshizawa, Y. Nakano, S. Furuta, Y. Akahane, K. Nishioka, R. H. Purcell, and H. J. Alter. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis and heptacellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
43. Klavinskis, L. S., A. Tishon, and M. B. A. Oldstone. 1989. Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo. J. Immunol 143:2013-2016.
44. Knapp, W., B. Dörken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein, and A. E. G. K. von dem Borne. 1989. Leucocyte typing IV: white cell differentiation antigens. Oxford University Press, Oxford.
45. Koziel, M. J., D. Dudley, N. Afdhal, Q.-L. Choo, M. Houghton, R. Ralston, and B. D. Walker. 1993. Hepatitis C virus (HCV) specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol 67:7522-7532.
46. Koziel, M. J., D. Dudley, J. T. Wong, J. Dienstag, M. Houghton, R. Ralston, and B. D. Walker. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339-3344.
47. Kozlowski, S., M. Coir, T. Takeshita, L. F. Boyd, C. D. Pendleton, R. N. Germain, J. A. Berzofsky, and D. H. Margulies. 1992. Serum angiotensin-1 converting enzyme activity processes an HIV 1 gp160 peptide for presentation by MHC class I molecules. J. Exp. Med. 175:1417-1422.
48. Kuo, G., Q.-L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, J. L. Dienstag, M. J. Alter, C. E. Stevens, G. E. Tegtmeier, F. Bonino, M. Colombo, W.-S. Lee, C. Kuo, K. Berger, J. R. Sinister, L. R. Overby, D. W. Bradley, and M. Houghton. 1989 An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364
49. - cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J. Virol 65:1823-1828
50. Lampson, L. A., and R. Levy. 1980. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125:293-299.
51. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus infection Microbiol. Rev. 57:183-289.
52. b binding motif. J. Immunol. 150:1212-1222.
53. Manabe, S., I. Fuke, O. Tanishita, C. Kaji, Y. Gomi, S. Yoshida, C. Mori, A. Takamizawa, I. Yosida, and H. Okayama. 1994. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 198:636-644.
54. Mitchell, L. C., L. S. Davis, and P. E. Lipsky. 1989. Promotion of human T lymphocyte proliferation by IL-4. J. Immunol. 142:1548-1557.
55. Mondelli, M., G. M. Vergani, A. Alberti, D. Vergani, B. Portmann, A. L. W. F. Eddleston, and R. Williams. 1982. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J. Immunol. 129:2773-2778.
56. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation Cell 54:777-785
57. Naumov, N. V., M. Mondelli, G. J. M. Alexander, R. S. Tedder, A. L. W. F. Eddleston, and R. Williams. 1984 Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus intection. Hepatology 4:63-68
58. Newberg, M. H., J. P. Ridge, D. R. Vining, R. D. Salter, and V. H. Engelhard. 1992. Species specificity in the interaction of CD8 with the α3 domain of MHC class I molecules J Immunol. 149:136-142.
59. Pamer, E. G., J. T. Harty, and M. J. Bevan. 1991. Precise prediction of a dominant class I MHC-restricted epitope of Listens monocytogenes. Nature (London) 353:852-855.
60. Plata, F., P. Langlade-Demoyen, J. P. Abastado, T. Berbar, and P. Kourilsky. 1987. Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo. Cell 48:231-240.
61. + cytotoxic T lymphocytes J. Virol. 67:801-806.
62. Saito, I., T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohta, Q.-L. Choo, M. Houghton, and G. Kuo. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci USA 87:6547-6549.
63. Schulz, M., R. M. Zinkernagel, and H. Hengartner. 1991 Peptide-induced antiviral protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA 88:991-993.
64. Sherman, L. A., T. A. Burke, and J. A. Biggs. 1992 Extracellular processing of peptide antigens that bind class 1 major histocompatibility molecules J Exp. Med. 175:1221-1226.
65. Shimonkevitz, R., S. Colon, J. W. Kappler, P. Marraek, and H. Grey. 1984. Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J. Immunol. 133:2067-2074
66. Shirai, M., T. Arichi, M. Nishioka, T. Nomura, K. Ikeda, K. Kawanishi, V. H. Engelhard, S. M. Feinstone, and J. A. Berzofsky. 1995. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J. Immunol. 154:2733-2742.
67. Shirai, M., H. Okada, M. Nishioka, T. Akutsuka, C. Wychowski, R. Houghten, C. D. Pendleton, S. M. Feinstone, and J. A. Berzofsky. 1994 Am epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J. Virol 68:3334-3342.
68. Simmonds, P., E. C. Holmes, T.-A. Cha, S.-W. Chan, F. McOmish, B. Irvine, E. Beall, P. L. Yap, J. Kolberg, and M. S. Urdea. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74:2391-2399
69. Sinigaglia, F., M. Guttinger, J. Kilgus, D. M. Doran, H. Matile, H. Etlinger, A. Trzeciak, D. Gillessen, and J. R. L. Pink. 1988. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature (London) 336:778-780.
70. Streicher, H. Z., I. J. Berkower, M. Busch, F. R. N. Gurd, and J. A. Berzofsky. 1984. The role of antigen conformation in determining requirements for antigen processing for T cell activation, p. 163-180. In E Sercarz, H Cantor, and L. Chess (ed.). Regulation of the immune system. Alan R. Liss, Inc., New York
71. Takamizawa, A., C. Mori, I. Fuke, S. Manabe, S. Murakami, J. Fujita, E. Onishi, T. Andoh, I. Yoshida, and H. Okayama. 1991 Structure and organization of the hepatitis C virus genome isolated from human carriers J. Virol. 65:1105-1113.
72. Taylor, P. M., and B. A. Askonas. 1986. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 58:417-420.
73. Tomei, L., C. Failla, E. Santolini, R. De Francesco, and N. La Monica. 1993 NS3 is serine protease required for processing of hepatitis C virus polyprotein. J. Virol. 67:4017-4026.
74. Tsubota, H., C. I. Lord, D. I. Watkins, C. Morimoto, and N. L. Letvin. 1989. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J. Exp. Med. 169:1421-1434.
75. Van der Poet, C. L., H. W. Reesink, P. N. Lelie, A. Leentvaar-Kuypers, Q.-L. Choo, G. Kuo, and M. Houghton. 1989. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet ii:297-298.
76. Vitiello, A., D. Marchesini, J. Furze, L. A. Sherman, and R. W. Chesnut. 1991. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class. I major histocompatibility complex J. Exp. Med. 173:1007-1015.
77. Walker, C. M., D. J. Moody, D. P. Stiles, and J. A. Levy. 1986. CD8 lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566.
78. Weiner, A. J., H. M. Geysen, C. Christopherson, J. E. Hall, T. J. Mason, G. Saracco, F. Bonino, K. Crawford, C. D. Marion, K. A. Crawford, M. Brunetto, P. J. Barr, T. Miyamura, J. McHutchinson, and M. Houghton. 1992 Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl Acad. Sci. USA 89:3468-3472.